CASI Pharmaceuticals CASIF
OTC CASIF
$0.12 +0.01 (+9.09%)
At close: Sep 30, 2026 · 4:00 PM EDT

CASI Pharmaceuticals (CASIF) Shares Outstanding (Entity) (2021 - 2025)

Updated

CASI Pharmaceuticals' Shares Outstanding (Entity) was 20.56 million in Q4 2025, up 32.7% from 15.49 million a year earlier.

Analysis

CASI Pharmaceuticals (CASIF) Shares Outstanding (Entity) (2021 - 2025) Analysis & Trends

From Q4 2021 onward, CASI Pharmaceuticals has reported Shares Outstanding (Entity) for 5 quarters.

  • Shares Outstanding (Entity) shows a five-year compound annual growth rate of 10.6% (FY2020 to FY2025).
  • In earlier years, Shares Outstanding (Entity) was 15.49 million in FY2024 (+15.8%), 13.38 million in FY2023 (-0.6%), 13.46 million in FY2022 (-3.7%) and 13.98 million in FY2021 (+12.8%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 CASI Pharmaceuticals 2.47 Mn -18.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 20.56 Mn
Dec 31, 2024 15.49 Mn
Dec 31, 2023 13.38 Mn
Dec 31, 2022 13.46 Mn
Dec 31, 2021 13.98 Mn
API Access

CASI Pharmaceuticals Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CASIF&period=max&api_key=YOUR_API_KEY